PATENT CLAIM ANALYSIS

Application Number: 16114940
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "094600"]

Abstract:
The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.

Claim (Index 24):
Use according to  claim 17 , wherein the administering is repeated at least once.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 96.0
- Lexical Diversity: 1.41463
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14921758', '12439517', '11390931', '11947952', '11253972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7375331859811278
- 35 USC 102 Novelty (BERT): 0.6351471283841768
- Combined Prediction Score: 0.7272945802214328
- Mean Citation Score: 359.567536
- Max Citation Score: 694.4281
- Similarity Product: 515.2566984553216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test